BRPI0820960B8 - composição, composição farmacêutica, e uso da composição - Google Patents
composição, composição farmacêutica, e uso da composiçãoInfo
- Publication number
- BRPI0820960B8 BRPI0820960B8 BRPI0820960A BRPI0820960A BRPI0820960B8 BR PI0820960 B8 BRPI0820960 B8 BR PI0820960B8 BR PI0820960 A BRPI0820960 A BR PI0820960A BR PI0820960 A BRPI0820960 A BR PI0820960A BR PI0820960 B8 BRPI0820960 B8 BR PI0820960B8
- Authority
- BR
- Brazil
- Prior art keywords
- composition
- antigen
- immune response
- enhancing
- pharmaceutical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
- C07H15/06—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical being a hydroxyalkyl group esterified by a fatty acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
- C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
- C07H5/04—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
- C07H5/06—Aminosugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Crystallography & Structural Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
Abstract
composição. são aqui fornecidas composições compreendendo o composto da fórmula. também fornecidos são métodos de melhorar uma resposta imune de um indivíduo a um antígeno administrando o antígeno e a composição. a melhor resposta imune pode ser uma resposta imune humoral, uma resposta de célula t cd4+, uma resposta de célula t cd8+ o resultar na ativação de células que apresentam antígeno. métodos de melhorar a resposta imune por administração intramuscular de um antígeno e a composição incluindo o composto da fórmula i também são fornecidos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US99246007P | 2007-12-05 | 2007-12-05 | |
PCT/IB2008/003945 WO2009101475A2 (en) | 2007-12-05 | 2008-12-05 | Compositions for and methods of enhancing the immune response to antigens |
Publications (3)
Publication Number | Publication Date |
---|---|
BRPI0820960A2 BRPI0820960A2 (pt) | 2017-05-09 |
BRPI0820960B1 BRPI0820960B1 (pt) | 2020-04-07 |
BRPI0820960B8 true BRPI0820960B8 (pt) | 2021-05-25 |
Family
ID=40788916
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0820960A BRPI0820960B8 (pt) | 2007-12-05 | 2008-12-05 | composição, composição farmacêutica, e uso da composição |
Country Status (14)
Country | Link |
---|---|
US (2) | US8207135B2 (pt) |
EP (1) | EP2231145B1 (pt) |
JP (1) | JP5813953B2 (pt) |
KR (1) | KR101566847B1 (pt) |
CN (1) | CN101917985B (pt) |
AU (1) | AU2008350531B2 (pt) |
BR (1) | BRPI0820960B8 (pt) |
CA (1) | CA2708246C (pt) |
DK (1) | DK2231145T3 (pt) |
ES (1) | ES2525127T3 (pt) |
PT (1) | PT2231145E (pt) |
RU (1) | RU2537188C2 (pt) |
WO (1) | WO2009101475A2 (pt) |
ZA (1) | ZA201003964B (pt) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8916164B2 (en) * | 2007-08-29 | 2014-12-23 | Abivax | Methods of enhancing adjuvaticity of vaccine compositions |
EP2058011A1 (en) * | 2007-11-07 | 2009-05-13 | Wittycell | Nkt cell activating gycolipids covalently bound antigens and/or drug |
JP6192120B2 (ja) | 2012-04-26 | 2017-09-06 | 国立研究開発法人理化学研究所 | 新規カルバメート糖脂質およびその用途 |
WO2015136027A1 (en) | 2014-03-13 | 2015-09-17 | Universitaet Basel | Carbohydrate ligands that bind to igm antibodies against myelin-associated glycoprotein |
CA2996073A1 (en) * | 2015-09-16 | 2017-03-23 | Universitat Basel | Carbohydrate ligands that bind to antibodies against glycoepitopes of glycosphingolipids |
EP3512557A1 (en) * | 2016-09-14 | 2019-07-24 | Abivax | Combinations including abx196 for the treatment of cancer |
DK3681512T3 (da) * | 2017-09-13 | 2021-09-06 | Abivax | ABX196 til anvendelse ved behandling af blærekræft |
CN110241060B (zh) * | 2019-08-02 | 2020-10-09 | 青岛农业大学 | 一种水貂肺炎克雷伯氏菌及其应用 |
Family Cites Families (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5242800A (en) | 1990-01-30 | 1993-09-07 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Receptor for pathogenic fungi |
US5936076A (en) | 1991-08-29 | 1999-08-10 | Kirin Beer Kabushiki Kaisha | αgalactosylceramide derivatives |
TW261533B (pt) | 1992-07-16 | 1995-11-01 | Kirin Brewery | |
WO1994009020A1 (en) | 1992-10-22 | 1994-04-28 | Kirin Beer Kabushiki Kaisha | Novel shingoglycolipid and use thereof |
ATE176237T1 (de) | 1993-04-15 | 1999-02-15 | Kirin Brewery | Sphingoglycolipid und verwendung davon |
CZ298895A3 (en) | 1993-05-14 | 1996-04-17 | Cytel Corp | Compound analogous to sialyl lex, pharmaceutical composition containing thereof and process for preparing lactosammonium salt |
US5785975A (en) | 1995-06-26 | 1998-07-28 | Research Triangle Pharmaceuticals | Adjuvant compositions and vaccine formulations comprising same |
EP0821068A3 (en) | 1996-03-29 | 1999-06-02 | Rohm And Haas Company | Novel sphingolipids and a process thereto |
US6417167B1 (en) | 1997-02-05 | 2002-07-09 | Kirin Beer Kabushiki Kaisha | Lyophilized compositions containing shingoglycolipid and process for preparing them |
ES2221147T3 (es) | 1997-02-05 | 2004-12-16 | Kirin Beer Kabushiki Kaisha | Composiciones liofilizadas conteniendo glicoesfingolipidos. |
TW592703B (en) | 1997-04-10 | 2004-06-21 | Kirin Brewery | NKT cell-activating agents containing alpha-glycosylceramides |
AU750141B2 (en) | 1997-12-30 | 2002-07-11 | A+ Science Invest Ab | Galactosylceramide, glucosylceramide, lactosylceramide, and specific catchers therefor for use in the prophylaxis or therapy of prediabetes, diabetes and/or associated complications |
WO1999041266A1 (en) | 1998-02-12 | 1999-08-19 | Emory University | Sphingolipid derivatives and their methods of use |
EP1277472A4 (en) | 2000-04-28 | 2005-06-08 | Orient Cancer Therapy Co Ltd | REMEDIES AGAINST CANCER |
JP4410913B2 (ja) | 2000-06-12 | 2010-02-10 | 壽製薬株式会社 | 新規糖脂質誘導体の製造方法 |
WO2001098317A2 (en) | 2000-06-22 | 2001-12-27 | The Brigham And Women's Hospital, Inc. | Alpha-glycosylceramides for treating bacterial and fungal infections |
AR034413A1 (es) | 2000-08-25 | 2004-02-25 | Nestor Abel Chamoles | Metodo para determinar la actividad de las enzimas lisosomales |
CN1561389A (zh) | 2001-07-25 | 2005-01-05 | 纽约大学 | 糖基神经酰胺作为用于抗传染病和癌症的疫苗的佐剂的用途 |
KR100549866B1 (ko) | 2001-08-22 | 2006-02-08 | 고려대학교 산학협력단 | 암치료 및 예방 제제 |
US20040266726A1 (en) | 2001-11-06 | 2004-12-30 | Akikuni Yagita | Anticancer compositions |
US7273853B2 (en) | 2002-05-13 | 2007-09-25 | Enanta Pharmaceuticals, Inc. | 6-11 bicyclic ketolide derivatives |
EP1551228B1 (en) | 2002-06-13 | 2012-10-03 | New York University | Synthetic c-glycolipid and its use for treating cancer infectious diseases and autoimmune diseases |
US7645873B2 (en) | 2003-03-20 | 2010-01-12 | The Scripps Research Institute | 6″-amino-6″-deoxygalactosylceramides |
GB0314682D0 (en) | 2003-06-24 | 2003-07-30 | Isis Innovation | Materials and methods relating to the modulation of T cell response to soluble antigen |
US7771726B2 (en) | 2003-10-08 | 2010-08-10 | New York University | Use of synthetic glycolipids as universal adjuvants for vaccines against cancer and infectious diseases |
JP2007531768A (ja) | 2004-03-31 | 2007-11-08 | ニューヨーク・ユニバーシティ | 感染症、癌および自己免疫疾患を治療するための新規な合成c−糖脂質、その合成および使用 |
AU2005282684B9 (en) | 2004-09-03 | 2011-07-07 | Brigham Young University | Methods of activating NKT cells |
AU2005322027B2 (en) | 2004-12-28 | 2013-09-12 | The Rockefeller University | Glycolipids and analogues thereof as antigens for NK Tcells |
JP5053101B2 (ja) | 2005-01-28 | 2012-10-17 | ブリガム ヤング ユニヴァーシティー | CD1d−拘束NKT細胞の細菌糖脂質による活性化 |
KR100764678B1 (ko) * | 2005-07-13 | 2007-10-09 | 재단법인서울대학교산학협력재단 | 알파-갈락토실세라마이드를 아쥬반트로 포함하는 비강투여용 백신 조성물 |
EP1776963A1 (en) * | 2005-10-19 | 2007-04-25 | Gbf-Gesellschaft Für Biotechnologische Forschung Mbh | Hexosylceramides as adjuvants and their uses in pharmaceutical compositions |
CN101331146B (zh) | 2005-10-25 | 2012-06-13 | 路德维格癌症研究院 | α-半乳糖神经酰胺的类似物及其用途 |
PT2056842E (pt) | 2006-04-07 | 2013-01-24 | Univ Chicago | Galactosil-ceramidas modificadas para coloração e estimulação de células t assassinas naturais |
EP2029165B1 (en) | 2006-04-27 | 2014-12-03 | Cellid Co., Ltd | B cell-based vaccine loaded with the ligand of natural killer t cell and antigen |
EP2040541B1 (en) | 2006-06-30 | 2016-03-23 | The Scripps Research Institute | Adjuvants and methods of use |
EP1938836A1 (en) | 2006-12-28 | 2008-07-02 | Universite Rene Descartes (Paris V) | Compositions comprising a B subunit of shiga toxin and a means stimulating NKT cells |
KR100868959B1 (ko) | 2006-12-30 | 2008-11-17 | 재단법인서울대학교산학협력재단 | 알파-갈락토실세라마이드 유도체, 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는면역보조용 약학적 조성물 |
US8916164B2 (en) | 2007-08-29 | 2014-12-23 | Abivax | Methods of enhancing adjuvaticity of vaccine compositions |
EP2058011A1 (en) | 2007-11-07 | 2009-05-13 | Wittycell | Nkt cell activating gycolipids covalently bound antigens and/or drug |
JP5809560B2 (ja) | 2008-10-08 | 2015-11-11 | アビヴァックス | インフルエンザに対して使用するためのワクチン組成物 |
-
2008
- 2008-12-05 US US12/315,702 patent/US8207135B2/en active Active
- 2008-12-05 RU RU2010127339/15A patent/RU2537188C2/ru active
- 2008-12-05 DK DK08872320.0T patent/DK2231145T3/en active
- 2008-12-05 CN CN200880119602.1A patent/CN101917985B/zh active Active
- 2008-12-05 EP EP08872320.0A patent/EP2231145B1/en active Active
- 2008-12-05 WO PCT/IB2008/003945 patent/WO2009101475A2/en active Application Filing
- 2008-12-05 ES ES08872320.0T patent/ES2525127T3/es active Active
- 2008-12-05 PT PT88723200T patent/PT2231145E/pt unknown
- 2008-12-05 CA CA2708246A patent/CA2708246C/en active Active
- 2008-12-05 KR KR1020107014861A patent/KR101566847B1/ko active IP Right Grant
- 2008-12-05 BR BRPI0820960A patent/BRPI0820960B8/pt active IP Right Grant
- 2008-12-05 US US12/746,488 patent/US8211861B2/en active Active
- 2008-12-05 AU AU2008350531A patent/AU2008350531B2/en active Active
- 2008-12-05 JP JP2010536551A patent/JP5813953B2/ja active Active
-
2010
- 2010-06-03 ZA ZA2010/03964A patent/ZA201003964B/en unknown
Also Published As
Publication number | Publication date |
---|---|
KR101566847B1 (ko) | 2015-11-06 |
EP2231145A2 (en) | 2010-09-29 |
JP5813953B2 (ja) | 2015-11-17 |
AU2008350531B2 (en) | 2014-01-23 |
RU2537188C2 (ru) | 2014-12-27 |
KR20100094556A (ko) | 2010-08-26 |
ES2525127T3 (es) | 2014-12-17 |
WO2009101475A3 (en) | 2009-10-22 |
AU2008350531A1 (en) | 2009-08-20 |
BRPI0820960B1 (pt) | 2020-04-07 |
DK2231145T3 (en) | 2014-12-08 |
US8211861B2 (en) | 2012-07-03 |
US20090162385A1 (en) | 2009-06-25 |
WO2009101475A2 (en) | 2009-08-20 |
CN101917985A (zh) | 2010-12-15 |
CA2708246A1 (en) | 2009-08-20 |
JP2011506306A (ja) | 2011-03-03 |
RU2010127339A (ru) | 2012-01-10 |
CA2708246C (en) | 2016-05-24 |
US20100322952A1 (en) | 2010-12-23 |
US8207135B2 (en) | 2012-06-26 |
ZA201003964B (en) | 2011-02-23 |
EP2231145B1 (en) | 2014-09-17 |
CN101917985B (zh) | 2014-07-02 |
BRPI0820960A2 (pt) | 2017-05-09 |
PT2231145E (pt) | 2014-12-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0820960B8 (pt) | composição, composição farmacêutica, e uso da composição | |
BRPI0515316A (pt) | compostos de imidazoquinolina | |
BRPI0510430A (pt) | composições e métodos para vacinação mucosal | |
CO6751288A2 (es) | Composición antigénica de micobacteria | |
CY1120622T1 (el) | Μεθοδοι και συνθεσεις για επαγωγη μιας ανοσιακης αποκρισης ως προς egfrviii | |
AR125327A2 (es) | Composiciones de neisseria meningitidis y métodos de las mismas | |
BR112013002940A2 (pt) | adjuvantes de nova vacina baseados no direcionamento dos adjuvantes para os anticorpos diretamente às células que apresentam antígenos | |
CO6311008A2 (es) | Composicion farmaceutica que comprende un agente que activa las celulas t regulatorias cd4+cd25+ | |
NO20064781L (no) | Fremgangsmater og adjuvanser for a forbedre immunresponser mot vaksiner og fremgangsmater for anvendelse | |
CY1114912T1 (el) | Εμβολιο για την προληψη της υποτροπης του καρκινου του μαστου | |
BRPI0411505A (pt) | uso de um composto, método para modular a resposta imune de um indivìduo, composição farmacêutica, vacina, complexo, e, kit para a captura de uma molécula biologicamente ativa | |
UY29395A1 (es) | Formulación de medicamentos conteniendo vardenafilo. | |
BRPI0713330A2 (pt) | adjuvantes e métodos de uso | |
BRPI0510394A (pt) | inibidores de 11-beta-hidroxiesteróide desidrogenase tipo 1 | |
AR085633A1 (es) | Coadyuvantes basados en anticuerpos que son dirigidos directamente a las celulas presentadoras en antigenos | |
AR059772A1 (es) | Composiciones que incuyen hemaglutinina metodos de elaboracion y metodos de uso de las mismas | |
ECSP11011115A (es) | Anticuerpos anti-pd-l1 y su uso para mejorar la función de células t | |
CY1107973T1 (el) | Σχετιζομενα με ογκους πεπτιδια, που συνδεονται ετεροκλητως με μορια κλασεως ιι αντιγονου ανθρωπινων λευκοκυτταρων | |
NZ609460A (en) | Method for activating helper t cell | |
BRPI0607605A2 (pt) | moléculas imunogênicas | |
BR0314898A (pt) | Compostos, composição cosmética, uso cosmético de uma composição, uso de um composto e composição farmacêutica | |
ECSP066912A (es) | Formulaciones de dispersiones sólidas de acetato de bazedoxifeno | |
EA200701172A1 (ru) | 2-алкокси-3,4,5-тригидроксиалкиламиды, их получение, композиции, их содержащие, и применение | |
TR200806298A2 (tr) | Farmasötik formülasyon | |
TR201818784T4 (tr) | Selenyum İle Kombinasyon Halinde Aronia Sp.'nin Bir Ekstraktını İçeren Bağışık Uyarıcı Terkip |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25A | Requested transfer of rights approved |
Owner name: ABIVAX (FR) |
|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 07/04/2020, OBSERVADAS AS CONDICOES LEGAIS. |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 05/12/2008 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |